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THE EFFECT OF BASIC 
FIBROBLAST GROWTH 
FACTOR ON THE BLOOD 
FLOW AND MORPHOLOGIC 
FEATURES OF A 
LATISSIMUS DORSI 
CARDIOMYOPLASTY 
Previous studies designed to determine whether latissimus cardiomyo- 
plasty could be used to revascularize ischemic myocardium showed that 
after operation the latissimus was ischemic and had severely deteriorated. 
This study was undertaken to determine whether basic fibroblast growth 
factor, a potent angiogenic peptide, would improve the vascularity of the 
latissimus and enhance collateral formation between the muscle of the 
cardiomyoplasty and ischemic myocardium. In goats, myocardial ischemia 
was induced with an ameroid constrictor and cardiomyoplasty performed. 
The latissimus was continuously stimulated electrically at 2 Hz for 6 weeks 
and given four weekly bolus injeetions of human reeombinant basic 
fibroblast growth factor (80 gg infused into the left subclavian artery). In 
eight animals, rates of regional blood flow were measured and both the 
heart and latissimus were evaluated histochemically. The latissimus blood 
flow rate was 0.114 _ 0.029 ml/gm per minute, which was three times 
greater than that of historical controls (chronically stimulated latissimus 
cardiomyoplasty without basic fibroblast growth factor treatment; 0.042 _ 
0.007 ml/gm per minute, p < 0.05). Associated with the improved blood 
flow, there was significantly less evidence of skeletal muscle fiber dropout 
and muscle fibrosis in the animals treated with basic fibroblast growth 
factor. Latissimus-derived collateral flow to ischemic myocardium devel- 
oped in five of the eight goats and averaged 0.288 - 0.075 ml/gm per 
minute. This flow was 42.8% - 15.7% (n = 5) of the flow required by normal 
myocardium (which was 0.728 -+ 0.095 ml/gm per minute). This value for 
latissimus-derived collateral blood flow was almost twice that of the 
historical controls (24.0% -+ 3.9%), but the increase did not achieve 
statistical significance (p = 0.08). These results hold the promise that basic 
fibroblast growth factor treatment might enhance the formation of ex- 
tramyocardial collaterals to the heart and improve skeletal muscle func- 
tion. (J THORAC CARDIOVASC SURG 1996;111:19-28) 
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A fter latissimus dorsi cardiomyoplasty, new blood vessels were formed between skeletal muscle and 
the heart in an experimental model of myocardial 
ischemia. 1 Blood flow through these collateral ves- 
sels averaged 25% of the flow required by normal 
myocardium when the latissimus was stimulated 
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either acutely or chronically. 2'~ However, chronic 
stimulation also decreased the blood flow of the 
latissimus dorsi muscle itself. 4 We postulated that 
infusion of an angiogenic factor would improve the 
vascularity and perfusion of the latissimus and 
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would further enhance collateral blood flow to the 
heart. If this hypothesis were supported, then car- 
diomyoplasty might be used to revascularize the 
myocardium of patients whose conditions are pres- 
ently inoperable because of extensive distal coro- 
nary disease. 
Basic fibroblast growth factor (bFGF) was se- 
lected for infusion in this study because of its potent 
angiogenic activity. 5' 6 bFGF is present in practically 
all tissues, 7' s and it may play a physiologic role in 
regulating vascularity. Endogenous bFGF expres- 
sion appears to be increased in electrically stimu- 
lated skeletal muscle 9 and in ischemic myocar- 
dium. 1°'11 We have also identified bFGF in 
chronically stimulated muscles used in cardiomyo- 
plasties. 12 Thus it appears plausible that exogenous 
infusion of bFGF  might improve the vascularity of 
skeletal muscle and might enhance the formation of 
extracardiac collaterals to ischemic myocardium. 
Methods 
Experimental design. We modified our goat model of 
cardiõmyoplasty and chronic myocardial ischemia 3 to 
administer bFGF directly into the arterial supply of the 
latissimus dorsi. Histochemical nd morphometric meth- 
ods were used to determine whether bFGF increased the 
vasculariLv of the latissimus. Microsphere injections were 
used to measure the effect of bFGF on latissimus blood 
flow and latissimus-derived collateral flow. The animals 
used in this study were cared for following the "Principles 
of Laboratory Animal Care" prepared by the National 
Society for Medical Research and the "Guide for the Care 
and Use of Laboratoly Animals" prepared by the Na- 
tional Academy of Science (NIH Publication No. 85-23, 
revised 1985). 
Latissimus dorsi cardiomyoplasty. Under sterile con- 
ditions, a latissimus dorsi muscle was prepared for car- 
diomyoplasty in 28 goats, as previously described. 3 An 
intramuscular electrode was woven around the ramifica- 
tions of the thoracodõrsal nerve (Medtronic Inc., Minne- 
apolis, Minn.) and connected to a pulse generator (Itrel 
model 7421, Medtronic Inc.). 
Chronic myocardial ischemia. Chronic myocardial 
ischemia was induced by placing an ameroid constrietor 
around a branch of the circumflex coronary arte~. Over 
the eourse of 2 to 3 weeks the ameroid eonstrictor absorbs 
water and slowly occludes the coronary artery. 
The area at risk for ischemia was defined by injecting 
microspheres into the left atrium during a temporary 
occlusion of the branch of the cireumflex artery. This 
injection also served to measure preexisting intracoronary 
collateral flow to the risk area. 
bFGF administration. A 4F silicone rubber catheter 
was inserted into the subclavian artery, upstream of the 
origin of the thoracodorsal rtery, through a left supra- 
clavicular incision. The catheter was secured with a purse- 
string suture and connected to a vascular access port hub 
implanted subcutaneously in the neck. 
Bolus injections of 80/xg of human recombinant bFGF 
(Synergen, Boulder, Colo.) were administered into the 
subclavian artery four times between postoperative days 
10 and 35. On the basis of the results of in vitro studies, ~3 
of the in vivo kinetic study reported by Edelman, Nugent, 
and Karnovsky, TM and of other animal studies, 1s-is 80 txg 
of bFGF by this route was likely to be an effective dose to 
promote angiogenesis n the latissimus. To maintain pa- 
tency, the catheter was flushed with 10 ml heparinized 
saline solution (4 units heparin per milliliter). 
Latissimus dorsi stimulation. Chronic, continuous 
electrical stimulation was begun on postoperative day 7. 
The pulse generator was initially set at 0.5 Hz and 3 volts. 
The freqnency was gradually increased to 2 Hz over 10 
days. The voltage was adjusted to maintain a palpable 
contraction. 
Hemodynamic and blood flow measurements. After the 
6-week periõd of electrical stimulation, the animals were 
anesthetized with sodium pentobarbital and the lungs 
ventilated artificially with 100% oxygen. Arterial blood 
pressure and the electrocardiogram were monitored and 
the time-tension index (time-tension index is equal to 
systolic pressure times heart rate) was calculated as an 
index of myocardial oxygen consumption. Amounts of 
regional blood flow were measured by injecting 15 million 
microspheres of orte color into the left atrium. 
Latissimus-derived collateral blood flow to the heart 
was measured by simultaneously injecting 7.5 million 
microspheres of another color into the subclavian artery. 
The microspheres were 15 ~m in diameter and were too 
large to recirculate. Therefore they could only enter the 
myocardium through collaterals with the latissimus. Latis- 
simus-derived collateral flow was calculated according to 
the formula previously developed. 3 
Histoiogie analysis and morphometry. The general his- 
tologic appearance of the latissimus was assessed from 
sections stained with hematoxylin and eosin (H & E). 
Vascularity of the latissimus was determined from capil- 
lary/fiber density ratios calculated from morphometric 
data. Masson's trichrome stain was used to identify areas 
of myoeardial infarction. 
General latissimus morphologic features. The right 
and left latissimus museles were evaluated subjectively 
from H & E-stained sections. Biopsy specimens were 
taken from the proximal, mid, and distal (attached to 
heart) latissimus dorsi and placed in formalin. The sam- 
ples were embedded in Paraplast medium and 7 /xm 
seetions were cut, Each slide was reviewed at × 100 and 
×200 magnification. The following qualitative observa- 
tions were made: (1) general morphologic features, rated 
as excellent, good, or poor, (2) presence or absence of 
cellular infiltrate, and (3) fiber dropout or fatty changes. 
The percentage of muscle fibers replaced by rat was 
estimated and eategorized as none, 1% to 25%, 26% to 
50%, or greater than 50%. Fatty areas were unstained and 
had a size similar to that of the muscle fiber they replaced. 
Quantitative assessment of the latissimus. In four an- 
imals, a quantitative evaluation of the latissimus was done 
by measuring capillary density, amount of extracellular 
collagen, fiber size, and the capillary/fiber ratio. Muscle 
biopsy specimens were taken from the mid latissimus of all 
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four animals. In two animals, biopsy specimens were also 
taken from the proximal and distal latissimus. 
The biopsy specimens were placed in Carnoy's olution 
overnight, dehydrated through graded ethanols, cleared in 
xylenes, and embedded in Paraplast medium. Ten serial 
sections 5 txm in thickness were cut from each block, 
mounted on glass slides, deparaffinized, and rehydrated. 
Sections were stained with (1) Griffonia simplicifolia 
agglutinin_B4 (GSA_B4) lectin19.2o (capillary density), (2) 
silver stain (extracellular collagen), 21 and (3) H & E (fiber 
size and density). Capillary/fiber ratio was calculated from 
the capillary and fiber densities. For each measurement, 
10 random fie][ds for each muscle slide were analyzed with 
computer-assisted chniques. 
GSA-B 4 (Sigma Chemical Co., St. Louis, Mo.) conju- 
gated to horseradish peroxidase was diluted 1:50 in phos- 
phate-buffered saline (PBS) solution and incubated on the 
tissue sections for 2 hours in a humidified chamber at 37 ° 
C. The slides were thoroughly rinsed in PBS solution. 
Sites of bound lectin were visualized by incubation in a 
3',3'-diaminobenzidine-hydrogen peroxide substrate me- 
dium followed by two additional rinses in PBS. 22 For a 
negative control, sections were incubated with nonconju- 
gated lectin. 
The stained sections were mounted on an inverted 
microscope (IM-35, Ziess, Munich, Germany) and imaged 
at a final magnification of ×400. The image was input 
through a high-resolution video camera (model 68, Dage, 
Michigan City, Ind.) connected to a computer image 
analysis systena (IBAS 2000, Ziess/Kontron, Munich, Ger- 
many). For each section, 10 random fields with an area 
25,390/xm 2 per field were analyzed. 
By computer-aided stereology, the number of ca pillar- 
ies per unit area (numeric density) was computed] ~'22, 23 
A computer-generated testframe automatically discrimi- 
nated the capillary profiles and determined the number of 
profiles within the test area with the use of exclusion-edge 
principlesY Capillary diameter was calculated by measur- 
ing the area of a stained vessel, transforming this area into 
a circle, and computing the diameter. This method for 
determining capillary diameter was used to avoid compu- 
tation errors for vessels in a transverse orientation. 
H & E-stained sections were viewed under epifluores- 
cent illumination to determine fiber size. The silver- 
stained secfions were used to determine the amount of 
extracellular connective tissue. Computer-assisted mor- 
phometry was used for both determinations. 
Myocardial infaretion. After the animals were killed, 
the heart was removed. The ventricles and attached 
latissimus muscle were cut into four concentric rings. 
Full-thickness ections were embedded in paraffin and 
stained with Masson's trichrome stain. Sections were 
mounted on a Reichert Diastar microscope (Leica, Inc., 
Deerfield, ill.) and imaged at ×25 magnification. The 
image was input through an RGB/YC/NTSC video cam- 
era (Worldwide Video, Inc., Boyertown, Pa.) connected to 
Bioquant System IV True Color Image Analysis system 
(R & M Bi0metrics, Nashville, Tenn.). Color thresholds 
were set manually to identify the portions of the section 
that were stained blue (for coUagen) or red (for viable 
tissue). Th~ system measured each area independently 
and calculated the percent of infarct in each section. 
Statistical analysis. Comparisons were made with 
paired or unpaired t tests as appropriate. A Bonferroni 
correction was made for multiple eomparisons. 
Results 
Technically satisfäctory results were obtained in 
eight animals and are presented hefe. There were 
five perioperative deaths caused by technical diffi- 
culties at the first operation. Ten animals died of 
sudden death between day 4 and day 37, presumably 
because of ischemic myocardium unprotected by 
collateral formation. In two animals, the subclaviän 
artery injection catheter failed and the animals did 
not receive bFGF. Ventricular fibrillation occurred 
in three animals after the induction of anesthesia for 
the finäl study, but before any hemodynamic or 
blood flow data could be obtained. The high mor- 
tality in the goat relative to that in the dog may be 
because of the almost complete lack of preexisting 
collaterals in the goat. All data are presented as 
mean plus or minus the standard error. 
Physiologic data 
Hemodynamics. Arterial blood pressure and 
heart rate were measured in all eight animals at 
the time that blood flow was measured. During the 
temporary occlusion of the coronary artery at the 
time of the first operation (referred to as acute 
occlusion), blood pressure was 79.8 + 4.7 mm Hg 
and was significantly lower than the 102.6 _+ 5.0 mm 
Hg (p < 0.05) observed during the measurements 
made after the coronary artery was occluded (re- 
ferred to as chronic occlusion). The lower pressure 
during the acute occlusion is attributable to the 
vasodilator effects of isoflurane anesthesia. During 
the final study, the animals were anesthetized with 
sodium pentobarbital. 
Heart rates during the acute and chronic o clu- 
sions were 88.8 2 5.2 and 88.3 _+ 6.5 beats/min, 
respectively. The time-tension index did not differ 
significantly during the acute and chronic occlu- 
sions: 9221 _+ 847 and 10,528 ± 841 mm 
Hg" beats • min -1, respectively. 
Latissimus dorsi blood flows. Rates of blood flow 
to the latissimus dorsi muscles are presented in 
Table I. The left latissimus muscle blood flow in this 
study with bFGF treatment was approximately three 
times higher than that reported by Bailey and asso- 
ciates 3 for chronically stimulated latissimus not 
given bFGF (p < 0.05, unpaired t test). 
The rates of blood flow to the unstimulated right 
latissimus dorsi muscles were not significantly dif- 
ferent during the acute and chronic coronary artery 
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Fig. 1. Latissimus-derived collateral blood flow (LDCBF) 
to chronically ischemic myocardium expressed as percent- 
age of flow delivered to normal myocardium. Closed 
circles represent animals that had development of signifi- 
cant collateral flow between latissimus and heart. Open 
circles represent animals that did not have such develop- 
ment. 
Table  I. Latissimus dorsi muscle blood ftow 
Acute Chronic 
occlusion occlusion 
Left latissimus flow (ml/gm/min) 
Mean 0.0845* 0.1140t 
SE 0.0292 0.0290 
n O 7 
Right latissimus flow (ml/gm/min) 
Mean 0.0350 0.0290 
SE 0.0174 0.0110 
n 6 7 
SE, Standard error. 
* Significantly different from right latissimus during acute occlusion (p < 
0.05). This elevation isan artifact secondary tomobilization of the muscle. 
? During the chronic occlusion measurement, after 6 weeks of chronic 2 Hz 
stimulation, the rate of left latissimus flow was significantly different from 
that of right latissimus (unstimulated). 
occlusions. During the chronic occlusion, the left 
latissimus was stimulated at 2 Hz and its flow was 
significantly higher than that of the unstimulated 
right latissimus. 
Regional myocardial blood flow. Regional myo- 
cardial blood flow rates for the normal, chronic 
ischemic, and infarcted myocardium are presented 
in Table II. Blood flow rates measured in the 
chronic ischemic zone during acute occlusion of the 
coronary artery were low and indicated that there 
were few native collaterals. 2»After chronic occlu- 
Tab le  II. Regional myocardial blood flow 
Acute Chronic 
occlusion occlusion 
Normal myocardial blood flow 
(ml/gm/min) 
Mean 0.6676 1.0446 
SE 0.1623 0.1648 
n 6 8 
Chronic ischemic myocardial blood flow 
(ml/gm/min) 
Mean 0.1281 0.7660 
SE 0.0620 0.1704 
n O 8 
Infarct blood flow 
(ml/gm/min) 
Mean 0.1228 0.1876 
SE 0.0632 0.2235 
n 3 5 
SE, Standard error. 
sion, ischemic zone blood flow was about 75% of 
that in the normal myocardium, which indicated that 
collaterals, both intramyocardial nd latissimus de- 
rived, had formed. 
Blood flow to the infarcted area was as low in the 
final study as it was during the acute occlusion. Only 
five goats had infarcts (defined as regional myocar- 
dial flow less than 30% of normal zone flow at the 
seventh postoperative week). 
Latissirnus-derived collateral blood flow. The latis- 
simus-derived collateral blood flow to ischemic myo- 
cardium was expressed as a percentage ofblood flow 
received by normal myocardium because of variabil- 
ity of the reference withdrawal method. Individual 
data points for latissimus-derived collateral blood 
flow are presented in Fig. 1. Five of the eight 
animals (closed circles) showed development of col- 
laterals between the latissimus and heart that con- 
tributed to coronary perfusion (flow greater than 10% 
of normal myocardial f ow). Only the data from the 
animals with collaterals will be considered, to facilitate 
comparison with previously published ata. 3
The latissimus-derived collateral blood flow aver- 
aged 42.8% + 15.7% of the flow delivered to the 
normal myocardium. In one animal, the latissimus 
delivered blood ftow to the chronically ischemic 
myocardium that was equal to 100% of the normal 
myocardial f ow. It is not known what factors caused 
some animals to have the development of such 
extensive collateral ftow from the skeletal muscle 
graft, whereas in others extracardiac ollaterals 
failed to develop. The total amount of flow delivered 
to the heart by the latissimus graft averaged 5.2 _+ 
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Table III. Comparison of the contribution of latissimus-derived collaterals with that of 
intracoronary collaterals 
Stimulation a Ione  Stimulation with bFGF 
Blood flow (ml/gm/min) 
Normal myocardial f ow 0.78 0.73 
SE 0.13 0.10 
Ischemic myocardial flow 0.61 0.50 
SE 0.09 0.03 
p = 0.07? p = 0.09? 
Percent of flow to ischemic myocardium by 
source of collateral flow 
Preexisdng collaterals 33.2 12.3 
SE 5.4 5.3 
New intracoronary cotlaterals 34.8 28.7 
SE 10.4 14.5 
Latissimus-derived collaterals 32.0 59.0 
SE 6.4 16.1 
n 10 5 
p = 0.80* 
p = 0.28* 
p = 0.03* 
p = 0.74* 
p = 0.08* 
SE, Standard error. 
* Independent t est comparJng stimulation with and without bFGF. 
+ Paired t test comparing ischemic and normal myocardial flow. 
1.5 ml/min (n = 5). Virtually all of this flow was 
delivered ~o the viable portion of the risk area. 
Comparison of latissimus-derived and intracoro- 
nary colla,~.eral flow. The blood flow to ischemic 
myocardium was partitioned into the contributions 
from preexisting collaterals, newly developed intra- 
coronary collaterals, and latissimus-derived collater- 
als, as described in the appendix. Table III compares 
the rates of flow during chronic occlusion from each 
source with those from our previous tudy in which 
bFGF was not infused. 3 
The means of the flows to the ischemic area 
tended to be lower than those of the normal zones, 
but were :not significantly lower. The flow from 
preexisting collaterals wa  significantly lower in the 
bFGF-treated animals. We deduced from the lower 
"preexisting" collateral flow that the Ameroid con- 
strictor mfist have been somewhat more proximal 
and hence freust have more completely arrested flow 
to the risk area. The flow from intracoronary collat- 
erals was !about the same in both groups, which 
suggests that bFGF administered to the latissimus 
did not increase the development of intracoronary 
collaterals.! The flow from the latissimus-derived 
collaterals'in the bFGF-treated group was almost 
twice that in the group without bFGF and ap- 
proached s~atistical significance. These data suggest 
I 
that bFGF i administration i to the latissimus dorsi 
can stimulate the formation of extracardiac collat- 
erals. 
Morphologic data 
Morphologic features of the right and lefi latissimus 
dorsi. The right latissimus dorsi was not mobilized 
or stimulated. It served as a control for the chroni- 
cally stimulated left latissimus. The right latissimus 
dorsi was found to be of excellent quality, with no 
cellular infiltrate. There was no fiber dropout. Each 
specimen demonstrated a minimal amount of peri- 
mysial connective tissue. 
Overall, similar muscle quality was observed in 
five of the eight left latissimus muscles and was rated 
as "excellent." Muscle quality was rated as "good" 
in the three other animals. Fiber dropout was less 
than 1% in one animal and less than 25% in the 
remaining seven animals. Cellular infiltrate was min- 
imal in seven of eight animals and moderate in the 
remaining animal. There was no evidence of subin- 
timal hyperplasia. 
Quantitative assessment of the lefi and right latissi- 
mus muscles. Fig. 2 shows representative photomi- 
crographs of serial sections of chronicaUy stimulated 
left latissimus muscle treated with bFGF and un- 
stimulated right latissimus. On the basis of the silver 
impregnation stain findings (top panels), there was 
no change in extracellular staining of the left latis- 
simus (Fig. 2, A) when compared with unstimulated 
control right latissimus (Fig. 2, B). However, the 
muscle fiber size appeared to be reduced in the left 
latissimus. Capillary density appeared to be in- 
creased in the chronically stimulated left latissimus 
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Fig. 2. Representative photomicrographs of ections taken from chronically stimulated ler and unstimu- 
lated control r]ght latissimus dorsi muscles (lefi and right panels, respectively). Top panels are muscle 
sections tained with use of silver-impregnation téchnique to quantitate extracellular matrix. Lowerpanels 
demonstrate muscle sections after lectin staining for capillaries. 
(Fig. 2, C), when compared with that in the control 
muscle (Fig. 2, D). 
The data for fiber size, amount of extracellular 
collagen, capillary density, andcapillary/fiber ratio 
are presented in Table IV. There were no statisti- 
cally significant differences in any of these values 
between the right and left latissimus. The lack of any 
significant differences is in agreement with our 
subjective conclusion that bFGF treatment protects 
against he deterioration usually seen in chronically 
stimulated muscles used in cardiomyoplasty. 
For two animals, regional differences in the cap- 
illary/fiber atio were examined. For the right (un- 
stimulated) latissimus, the ratio was the same for the 
proximal, mid, and distal regions. However, the 
ratio for the proximal left (stimulated) latissimus 
was three times greater than that for the right 
latissimus and greater than that for the mid and 
distal regions of the left latissimus. The increase in 
the ratio was primarily as a result of higher capitlary 
densities. Similar results were found in both ani- 
mals. 
Myocardial infarct. The total left ventricular 
weight was 73.27 _ 5.71 gm (n = 8). The risk area 
(chronically ischemic myocardium plus infarcted 
myocardium) was 25.8% + 3.6% of the left ventri- 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 111, Nurnber t 
Mannion et al. 2 5 
cle. Approximately one fourth of the myocardial risk 
area (28.4% + 3.8%) was infarcted. All eight ani- 
mals showed histologic evidence of infarct. Most of 
the infarct was in the subendocardial region. 
Discussion 
There are three principal findings of this study. 
First, bFGF treatment significantly improved the 
perfusion of the chronically stimulated latissimus 
muscle after cardiomyoplasty. Second, associated 
with the improved perfusion was an improved mor- 
phologic appearance of the latissimus when com- 
pared with that in previous reports. 3'26-28 Third, 
there was a trend to an increased latissimus-derived 
collateral blood flow to chronicaIly ischemic myo- 
cardium. 
Vascularity of the latissimus. We postulated that 
bFGF would increase the vascularity, and hence the 
perfusion, of the latissimus. In this study, we com- 
pared the capillary density and capillary/fiber ratio 
of stimulated latissimus with those values in the 
right-sided control muscles in animals treated with 
bFGF. The capillary density and capillary/fiber ratio 
were elevated only in the proximal left (stimulated) 
latissimus in comparison with values in the unstimu- 
lated right latissimus. This effect has been reported 
by many others (see Hudlicka. Brown, and Eggin- 
ton 29 for a review). Associated with the increased 
vascularity of the latissimus was an increase in its 
blood flow. 
The failure of the mid and distal latissimus to
show increased capillary/fiber ratios may be related 
to the fact that the circulation was compromised by 
severance of the perforating intercostal arteries 
during mobilization. Hudlicka and Price 3° have re- 
ported that the capillary/fiber ratio was not in- 
creased by chronically stimulating in situ skeletal 
muscles with compromised blood supplies. None- 
theless, the latissimus blood flow values in the mid 
and distal regions were elevated compared with 
those in the right latissimus and in historical con- 
trols. Therefore it appears that bFGF treatment 
maintained a level of vascularity that was sufficient 
to support a threefold increase in blood flow during 
chronic stimulation compared with that seen in 
response to chronic stimulation m muscles used in 
cardiomyoplasties without bFGF treatment. 
Latissimus dorsi blood flows after mobilization. 
Immediately after mobilization of the left latissimus 
(acute occlusion measurement), he rate of left 
latissimus blood flow was significantly higher than 
that of the right (p < 0.05). This finding would 
Table IV. Summary of morphometric analysis 
LLD RLD 
Fiber size (cross-sectional rea,* /xm 2) 
Mean 1365 1647 
SE 121 115 
Collagen content (percent of field) 
Mean 18.4 16.4 
SE 1.7 1.0 
n 4 4 
Capillary density (no. of capillaries per mm 2) 
Mean 1222 1042 
SE 114 247 
n 4 4 
Capillary/fiber ratiot 
Mean 2.59 2.26 
SE 0.45 0.39 
n 4 4 
LLD, Chronically stirnulated left latissimus dorsi (midregion); RLD, 
unstimulated right latissimus dorsi (midregion); SE, standard error. 
*Calculated using an elliptical model from the major and minor axes of the 
individual fibers. 
tCalculated as capillary density/fiber density. Fiber density calculated as 
the quotient of area not occupied by collagen or capillaries divided byfiber 
size. 
appear to be inconsistent with the fact that the 
perforating intercostal rteries and other distal col- 
laterals were severed. However, we have repeatedly 
observed elevated blood flow values in the muscle 
flaps immediately after mobilization, as have oth- 
ers. 1-4'31'32 This increase may be the result of an 
inflammatory esponse caused by the mobilization 
procedure, interruption of sympathetic nerves, or 
both of these events. Although we have no data that 
bear on the mechanism, it is clear that it was 
sulficient to overcome any deficit caused by compro- 
mising the vascular suppiy. 
Muscle morphologic features and correlation 
with muscle function. In the present study there 
was minimal fiber dropout, no significant increase in 
extracellular connective tissue, and no subintimal 
hyperplasia compared with the unstimulated right 
latissimus. These findings are in contrast o the 
evidence of latissimus degeneration seen in our 
historical controls 3'4 and reported by Lucas and 
colleagues 33and Kratz and colleagues. 27These mor- 
phologic changes were correlated with impaired 
muscle function. 27 Because bFGF administration 
appears to have preserved the architecture of the 
muscle, it can be postulated that bFGF-treated 
muscles would have better function than muscles 
not treated with bFGF used in cardiomyoplasties. 
Our finding of minimal subintima! hyperplasia s
also in contrast o the reports of others. Severe 
intimal hyperplasia and proliferation of smooth 
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muscle cells in small arteries have been associated 
with both chronic stimuiation 33 and infarcted myo- 
cardium treated with acidic fibroblast growth fac- 
tor. 26 Reduced hyperplasia would contribute to bet- 
ter perfusion and muscle function. 
Latissimus-derived collateral blood flow. bFGF 
augmented the amount of latissimus blood flow, but 
did not augment he amount of extramyocardial 
collateral blood flow. We postulated that bFGF 
infusion would augment collateral f ow by increasing 
the vascularity and blood flow of the latissimus 
muscle and reducing infarct size. 4 However, the 
almost doubling of the contribution of the latissimus 
dorsi to perfusion of ischemic myocardium com- 
pared with results in historical controls 3 was not 
statistically significant. 
Potential reasons bFGF would increase angiogen- 
esis within the muscle, but not in the heart, ~ may be 
related to the route, dosage, and schedule of bFGF 
administration. The dosage of bFGF to the latissi- 
mus appeared to be adequate. With an 80/xg bolus 
of bFGF, assuming a subclävian artely blood flow 
rate of 200 tal/min and a thoracodorsal rtery blood 
flow rate of 8.5 tal/min, approximately 3.6 /zg of 
bFGF was infused initially into the latissimus dorsi 
muscle. Baffour and ässociates I5 injected 1 to 3 wg 
bFGF per day directly into an ischemic hindlimb 
skeletal muscle and reported increased angiogene- 
sis. 
However, the dose received by the heart might 
have been too low. In our study, less than 3.6/xg of 
bFGF would have been received by the myocardium 
after recirculation and dilution by the cardiac out- 
put. This dose was smaller than that used by other 
investigators who demonstrated some beneficial ef- 
fects of bFGF administration to the myocardi- 
um. 16-18 It is possible that an intracoronary oute 
would have more vigorously stimulated the develop- 
ment of collaterals from the latissimus to the heart. 
Because bFGF was given in periodic bolus injec- 
tions, it is possible that its delivery might not have 
coincided with the most optimal time in the course 
of the development of myocardial ischemia. After 
administration, bFGF is bound to storage sites on 
the extraceUular matrix, and it appears to be metab- 
olized within 24 hours. 13 In contrast, he successful 
stimulation of angiogenesis within the latissimus 
could be attributed to the fact that it was continu- 
ously stimulated. Hence, bFGF would have been 
delivered to the latissimus during periods of in- 
creased oxygen demand that could not be met by its 
compromised vascular supply. 
Possible mechanisms for the effect of bFGF on 
the latissimus, bFGF is a multifunctional peptide 
and it could improve muscle morphologic features 
through several different mechanisms. First, the 
neurotrophic effects 34 of bFGF might mitigate neu- 
rogenic damage induced by continuous electrical 
stimulation. Second, bFGF stimulates proliferation 
of myoblasts and may have stimulated regeneration 
of the injured skeletal muscle. 35-37 Thus bFGF 
might not necessarily prevent ischemic muscle dam- 
age, but rather might promote recovery from it. 
Third, bFGF is a potent angiogenic peptide, 5'6 and 
it might accelerate cäpilläry growth and improve 
muscle blood flow, before ischemic dämage could 
oecur. 
bFGF is a member of a family of peptide growtb 
factors that have been demonstrated to modulate 
angiogenesis during growth and development, 3& 39 
but its only normal, physiologic role in adults ap- 
pears to be during pregnancy, follicle development, 
and ovulation. » However, growth factors have been 
identified as having a prominent role in response to 
injury, ischemia, diabetes, and tumor growth. 5'39 
Recently, infusion of bFGF and of other angiogenic 
agents has been found to increase revascularization 
of ischemic skeletal muscle 15'40'41 and myocardi- 
um.16-18, 42 
At present, the most likely mecbanism for the 
effect of bFGF on a latissimus muscle used for 
cardiomyoplasty appears to be the acceleration of 
angiogenesis. There does not appear to be uniform 
histologic evidence of extensive fiber destruction 
and regeneration. However, conclusive vidence for 
prevention of muscle damage by enhancement of 
skeletal muscle blood flow requires further study. 
Clinical implications, bFGF administration re- 
sulted in an improved perfusion of the latissimus. 
This finding is significant because chronic ischemic 
injury of the latissimus has been recognized as 
contributing to a lack of efficacy in both clinica143-46 
and experimenta127' 33, 47-50 cardiomyoplasties. 
Some work has been done to overcome the prob- 
lem of ischemia in the latissimus. A delay period 
between mobilization and the onset of electrical 
stimulation was shown to minimize ischemic dam- 
age, 49 but the complete prevention of damage was 
not demonstrated. The optimal ength of the delay 
period and the optimal initial stimulation patterns 
have not been precisely defined. Stimulation of a 
mobilized muscle after clinical and experimental 
cardiomyoplasties still leads to ischemic muscle 
damage. 
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Study limitations. The main limitation of this 
study is that bFGF-treated muscles used in cardio- 
myoplasties were compared with historical control 
muscles not treated with bFGF. Further investiga- 
tion will be required to confirm that bFGF is helpful 
in preventing skeletal muscle ischemia after a car- 
diomyoplasty. 
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Appendix 
In animals with a eompletely obstructed coronary ar- 
tery, the total flow to the ischemic myocardium is deliv- 
ered by preexisting intracoronary collaterals, new intra- 
eoronary collaterals, and the newly formed latissimus- 
derived collaterals. Preexisting eollateral flow as a 
percentage of normal myocardial flow was determined by 
microsphere injection during the aeute ocelusion. At the 
final study, the same percentage of total flow is delivered 
to the ischemic myocardium. Therefore subtraction of the 
preexisting collateral flow and the latissimus-derived col- 
lateral flow from the total flow yields the flow via newly 
formed intracoronary collaterals. 
Intracoronary collateral f ow 
= Total ischemic flow - Latissimus-derived 
collateral f ow - Preexisting collateral f ow 
where preexisting collateral flow equals total ischemic 
flow × (acute occlusion ischemic zone flow)/(acute occlu- 
sion normal myocardial flow). 
